Skip to content

Addiction: all studies

Page 197 of 855: studies 1,961 to 1,970 of 8,547, newest first. Back to the addiction overview

Research

Navigating the Storm: How Does Meditation Influence Mental Health Among Older Adults With Chronic Conditions?

Journal of Population Ageing April 18, 2026 Sofia von Humboldt, Isabel Leal

Abstract Meditation can act as a protection for mental well-being in late years, by helping older adults to challenge the pervasive effects of chronic illness. The primary objectives of this qualitative research study are to: (a) to examine older adults’ experiences of meditation while living with chronic disease, and (b) to analyze how meditation is perceived to influence their mental health....

Isotopic DMT as a Probe of Spin-Dependent Psychedelic Pharmacology

Zenodo (CERN European Organization for Nuclear Research) April 18, 2026 preprint

We propose a three-phase experimental protocol testing whether the radical pair mechanism (RPM) operates during N,N-dimethyltryptamine (DMT)-induced psychedelicstates at the 5-HT2A receptor. Position-specific isotopic substitution of the ligand (13C at C3a, 15N on indole nitrogen) modifies nuclear spin content without altering molecular geometry, receptor affinity, or metabolic...

DOI: 10.5281/zenodo.18965900 (opens in new tab) Kinetic isotope effect Deuterium Isotopomers Hyperfine structure +9

Psychedelics: Historical Context, Emerging Science, and Future Clinical Frontiers

Journal of Mental Health Disorders April 18, 2026 Vipul Janardan, Amit Khanna, Om Prakash et al.

Psychedelics a class of psychoactive compounds such as psilocybin, lysergic acid diethylamide (LSD), and dimethyltryptamine (DMT) are undergoing a scientific renaissance. Studies since 2020 have shown their therapeutic promise in mental health treatment. This Commentary synthesizes historical usage, current neuroscientific and clinical evidence, and explores ethical and regulatory frontiers for...

Psychedelics and Autism Therapy: A Review of Current Research and Future Directions

Current Issues in Molecular Biology April 18, 2026 Christopher S. Gondi, Manu Gnanamony, Tarun P. Gondi et al.

Autism Spectrum Disorder (ASD) is a lifelong condition marked by challenges in social communication and repetitive behaviors. Current treatments, primarily behavioral therapies, often fail to address the core symptoms. Recent research has explored the potential of psychedelics, such as LSD, psilocybin, and MDMA, as a new therapeutic approach. While these substances primarily modulate the...

DOI: 10.3390/cimb48040417 (opens in new tab) Neuroplasticity Glutamatergic Autism spectrum disorder Therapeutic approach +2

Electrocorticographic Changes and Neuronal Maturation in the Antidepressant-like and Anxiolytic Effects of Micro- or Macrodosing of Psilocybe cubensis Mushroom in Mice

Molecules April 18, 2026 Flor Eréndira Sánchez-cortés, Nelly Maritza Vega-Rivera, Raúl Iván Escamilla-Orozco et al.

Mushroom use dates back to ancient times, and it currently remains significant among indigenous and urban populations as a medicinal option. Psilocybe species are suggested to modify emotions when administered in macro- or microdose form for the treatment of anxiety and depression, both often affected by a delayed onset and adverse effects of current pharmacological therapy. The objective of...

DOI: 10.3390/molecules31081331 (opens in new tab) Anxiolytic Fluoxetine Hippocampus Corticosterone +5

Undoing Cambodia’s Cosmopolitical Fix: Forests, Sweatshops, and Possibilities for Uncommon Alliances

Ethnos April 17, 2026 Casper Bruun Jensen, Sarah Milne, A Blok 1 citation

The Cambodian regime depends on large-scale extraction of natural resources. However, the regime also acknowledges that Cambodian territories are potent landscapes protected by extra-human beings. Hence, it must accomplish seemingly contradictory objectives: pleasing the land-protectors while ruining the lands they protect. We characterise this effort as Cambodia’s cosmopolitical fix. To...

Envisioning Cannabinoid CB1 Receptor Biased Signaling as a Therapeutic Target for Schizophrenia.

American Journal of Psychiatry April 17, 2026 Shih-Hsuan Ku, Sierra J Stringfield, Mary M Torregrossa et al.

The relationship between the endocannabinoid system and the emergence and treatment of schizophrenia-related symptoms continues to be a topic of significant interest within psychiatry. Cannabis is the most widely used recreational drug worldwide, and individuals with schizophrenia use it at a much higher rate than the general population. The shared genetic risk for schizophrenia and cannabis...

A New Use for an Old Compound: Microdosing LSD to Reduce Fibromyalgia Symptoms

April 17, 2026 Sara Arciniegas Ruiz, Sari Prutchi Sagiv, Hagit Eldar-Finkelman

Fibromyalgia (FM) is a chronic pain condition characterized by widespread pain, fatigue, sleep disturbances, and mood changes. Available treatments often provide limited relief, highlighting the need for new therapeutic approaches. Repurposing offers a faster and more cost-effective path to innovation. Lysergic acid diethylamide (LSD), historically known for its psychedelic effects, has...

Impact of psilocybin and Psilocybe cubensis extract on gut microbiota in Wistar Han rats

Science Letters April 17, 2026 Francisco Sacadura, Cláudia Marques, Andreia Machado Brito-Da-Costa et al.

Background: Psilocybin, the main psychoactive compound found in Psilocybe mushrooms, has gained increasing attention due to its potential therapeutic effects in neuropsychiatric disorders [1]. Beyond its central effects, increasing evidence highlights the relevance of the gut–brain axis, suggesting that psychedelics may also influence intestinal microbiota composition. Whole mushroom extracts...

DOI: 10.48797/sl.2026.492 (opens in new tab) Psilocybin Gut flora Amplicon sequencing Mushroom +5

Psilocybin reshapes cortical inhibition through selective interneuron recruitment.

bioRxiv : the preprint server for biology April 17, 2026 Pasha A. Davoudian, Quan Jiang, Cory A. Knox et al. preprint

Psychedelics show therapeutic potential for treating psychiatric disorders. While studies have emphasized the roles of cortical pyramidal cells, GABAergic neurons also express serotonin receptors and are therefore likely targets of psychedelics. In this study, we determine the effect of psilocybin on the activity dynamics of major GABAergic cell types in the mouse medial frontal cortex....